Julia Hoefer - Concepedia

Author

Julia Hoefer

Innsbruck Medical University ORCID

Also Known As

Hoefer, Julia, J Hoefer, J. Hoefer, Julia Hoefer

Publications

997

Citations

H-Index

Concepts

All Affiliations

Innsbruck Medical University Universität Innsbruck University Hospital Bonn Institut Pasteur de Lille Karolinska University Hospital

About

Julia Hoefer is an author at Innsbruck Medical University specializing in medicine, signal transduction, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	78
2	Health Sciences	1	1	32
3	Cell Biology	1	1	46
4	Immunology	1	1	32
5	Pharmacology	1	1	32

Julia Hoefer

Publications

990

Citations

H-Index

Page 1

	Year	Citations
Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205 Martin Puhr, Julia Hoefer, Georg Schäfer, American Journal Of Pathology	2012	258
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy Martin Puhr, Julia Hoefer, Andrea Eigentler, Clinical Cancer Research	2017	166
PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21 Julia Hoefer, Georg Schäfer, Helmut Klocker, American Journal Of Pathology	2012	78
Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide Julia Hoefer, Mohammady Akbor, Florian Handle, Oncotarget	2016	55
The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice Ivan Tancevski, Egon Demetz, Kristina Duwensee, PLoS ONE	2010	50
SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer Julia Hoefer, Johann Kern, Philipp Ofer, Endocrine Related Cancer	2013	50
PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer Martin Puhr, Julia Hoefer, Andrea Eigentler, Oncogene Androgen ReceptorUrologySignal TransductionPoor SurvivalGenitourinary Cancer	2015	46
The “Aging Factor” Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor’s Age Julia Hoefer, Markus Luger, Christian Dal‐Pont, Frontiers in Aging Neuroscience	2017	44
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models Florian Handle, Martin Puhr, Georg Schaefer, Molecular Cancer Therapeutics	2018	43
SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells Florian Handle, Holger H.H. Erb, Birgit Luef, Molecular Cancer Research	2016	41

Page 1